journal article·2018-09

Fluorescein‐Loaded Solid Lipid Nanoparticles Based on Monoamine Pillar[5]arene: Synthesis and Interaction with DNA

L. S. Yakimova, D. N. Shurpik, E. G. Guralnik, V. G. Evtugyn, Y. N. Osin, I. I. Stoikov

ChemNanoMat· Volume 4· Issue 9
Publisher page

Abstract

Abstract Present research is the first example to use pillar[5]arene for creation fluorescein‐loaded solid lipid nanoparticles and release dye during interaction with DNA ‐ potential delivery system of the imaging agent. Monoamine functionalized pillar[5]arene was synthesized for preparation of the solid lipid nanoparticles (SLN) with/without luminescent marker (fluorescein). Interestingly, presence of a single tail‐group in the pillar[5]arene has opened wide opportunities for the formation of the various types of pillararene‐based assemblies, i. e., pseudorotaxanes, supramolecular polymers and SLNs, varying the solvents.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Supramolecular Chemistry and Complexes · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Kazan Federal University A.M. Butlerov Chemical Institute 420008 Kremlevskaya Street, 18 Kazan Russian Federation

Department Kazan Federal University Interdisciplinary Centre for Analytical Microscopy 420008 Kremlevskaya Street, 18 Kazan Russian Federation

Funding

Russian Science Foundation

References (55)

Show source-provided references
1.
2. 10.1016/j.yexmp.2008.12.00410.1016/j.yexmp.2008.12.004 ↗
3. 10.1016/j.msec.2015.11.06710.1016/j.msec.2015.11.067 ↗
4.
5. 10.1016/j.addr.2007.05.00610.1016/j.addr.2007.05.006 ↗
6. 10.1016/j.addr.2007.10.01010.1016/j.addr.2007.10.010 ↗
7. 10.1016/j.addr.2003.12.00210.1016/j.addr.2003.12.002 ↗
8.
9. 10.1016/S0378-5173(02)00639-710.1016/S0378-5173(02)00639-7 ↗
10. 10.1016/j.mencom.2015.05.00510.1016/j.mencom.2015.05.005 ↗
11. 10.1039/C6RA07555J10.1039/C6RA07555J ↗
12. 10.1016/j.ijpharm.2017.02.02210.1016/j.ijpharm.2017.02.022 ↗
13. 10.1039/C6SM00661B10.1039/C6SM00661B ↗
14. 10.1016/j.colsurfb.2015.06.02710.1016/j.colsurfb.2015.06.027 ↗
15. L. S. Yakimova D. N. Shurpik L. H. Gilmanova A. R. Makhmutova A. Rakhimbekova I. I. Stoikov Org. Biomol. Chem.2016 14 4233–4238;10.1039/C6OB00539J ↗
16. 10.1039/C5NJ01951F10.1039/C5NJ01951F ↗
17. 10.6060/mhc140719s10.6060/mhc140719s ↗
18. 10.1016/j.electacta.2014.10.00710.1016/j.electacta.2014.10.007 ↗
19. 10.6060/mhc140928s10.6060/mhc140928s ↗
20. 10.6060/mhc170511s10.6060/mhc170511s ↗
21. 10.1039/C6NJ03345H10.1039/C6NJ03345H ↗
22. 10.1039/C6CC05797G10.1039/C6CC05797G ↗
23.
24. 10.1039/b600720c10.1039/b600720c ↗
25. 10.1039/C4CC01372G10.1039/C4CC01372G ↗
26. 10.1039/C5CC04079E10.1039/C5CC04079E ↗
27. 10.1039/c4cc00997e10.1039/c4cc00997e ↗
28. 10.1039/C5RA13195B10.1039/C5RA13195B ↗
29. 10.1039/c1cc15660h10.1039/c1cc15660h ↗
30. 10.1002/chem.20140319410.1002/chem.201403194 ↗
31. 10.3390/s1710243010.3390/s17102430 ↗
32. 10.1039/C7CC05157C10.1039/C7CC05157C ↗
33. 10.1080/10610278.2015.111137510.1080/10610278.2015.1111375 ↗
34. 10.1016/j.snb.2015.11.02310.1016/j.snb.2015.11.023 ↗
35.
36. 10.1021/cr500633b10.1021/cr500633b ↗
37. 10.1039/C6CC03999E10.1039/C6CC03999E ↗
38. 10.1039/C6PY01961G10.1039/C6PY01961G ↗
39. 10.1039/C5RA09253A10.1039/C5RA09253A ↗
40. 10.1021/jo102082310.1021/jo1020823 ↗
41. 10.1134/S107036321603043910.1134/S1070363216030439 ↗
42. 10.1039/C5RA09253A10.1039/C5RA09253A ↗
43. 10.1039/C6PY01123C10.1039/C6PY01123C ↗
44.
45. 10.1016/j.scp.2017.07.00210.1016/j.scp.2017.07.002 ↗
46. 10.3109/1061186X.2012.71684510.3109/1061186X.2012.716845 ↗
47. Kumar M. · J. Pharm. Pharm. Sci. · 2000 · 3 · 234
48. 10.1016/S0169-409X(01)00105-310.1016/S0169-409X(01)00105-3 ↗
49. 10.1016/j.jbiotec.2004.06.00710.1016/j.jbiotec.2004.06.007 ↗
50. 10.1021/nn402777x10.1021/nn402777x ↗
51.
52. 10.1039/C7CC00950J10.1039/C7CC00950J ↗
53. 10.1039/C7CC02364B10.1039/C7CC02364B ↗
54. 10.1002/mrc.246010.1002/mrc.2460 ↗
55. 10.1002/chem.20110063410.1002/chem.201100634 ↗